Semaglutide Linked to 42% Fewer Psychiatric Hospital Episodes
Semaglutide Linked to 42% Fewer Psychiatric Hospital Episodes TL;DR: In Swedish registry data covering nearly 100,000 people with depression or anxiety, psychiatric hospital visits and sickness absence were 42% lower during semaglutide treatment periods — with comparable reductions in depression, anxiety, and substance-use outcomes. Key Findings 42% lower psychiatric care during semaglutide periods: Psychiatric hospital …
